دورية أكاديمية

Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin.

التفاصيل البيبلوغرافية
العنوان: Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin.
المؤلفون: Damiano, L, Stewart, K M, Cohet, N, Mouw, J K, Lakins, J N, Debnath, J, Reisman, D, Nickerson, J A, Imbalzano, A N, Weaver, V M
المصدر: Oncogene; 5/8/2014, Vol. 33 Issue 19, p2441-2453, 13p
مصطلحات موضوعية: ONCOGENES, GENE targeting, EPITHELIAL cells, INTEGRINS, INTEGRIN genetics, GENE expression, STROMAL cells, CELL communication
مستخلص: Integrin expression and activity are altered in tumors, and aberrant integrin signaling promotes malignancy. However, how integrins become altered in tumors remains poorly understood. We discovered that oncogenic activation of MEK signaling induces cell growth and survival, and promotes the malignant phenotype of mammary epithelial cells (MECs) by increasing α5 integrin expression. We determined that MEK activates c-Myc to reduce the transcription of the SWI/SNF chromatin remodeling enzyme Brahma (BRM). Our studies revealed that reduced BRM expression and/or activity drives the malignant behavior of MECs by epigenetically promoting C/EBPβ expression to directly induce α5 integrin transcription. Consistently, we could show that restoring BRM levels normalized the malignant behavior of transformed MECs in culture and in vivo by preventing C/EBPβ-dependent α5 integrin transcription. Our findings identify a novel mechanism whereby oncogenic signaling promotes malignant transformation by regulating transcription of a key chromatin remodeling molecule that regulates integrin-dependent stromal-epithelial interactions. [ABSTRACT FROM AUTHOR]
Copyright of Oncogene is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:09509232
DOI:10.1038/onc.2013.220